Ketoconazole-
4-Aminobenzoic Acid
/ administration & dosage
Administration, Oral
Animals
Antifungal Agents
/ administration & dosage
Biological Availability
Candida
/ drug effects
Cell Survival
/ drug effects
Cells, Cultured
Crystallization
Drug Combinations
Drug Compounding
/ methods
Drug Stability
Female
Fibroblasts
/ drug effects
Human Umbilical Vein Endothelial Cells
/ drug effects
Humans
Ketoconazole
/ administration & dosage
Rats
Solubility
Toxicity Tests, Acute
Water
/ chemistry
bioavailability
biological assay
cocrystal
ketoconazole
p-aminobenzoic acid
physical stability
solubility
Journal
Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791
Informations de publication
Date de publication:
02 03 2020
02 03 2020
Historique:
pubmed:
28
1
2020
medline:
27
5
2021
entrez:
28
1
2020
Statut:
ppublish
Résumé
The 1:1 cocrystal of the antifungal agent ketoconazole with
Identifiants
pubmed: 31986050
doi: 10.1021/acs.molpharmaceut.9b01178
doi:
Substances chimiques
Antifungal Agents
0
Drug Combinations
0
Water
059QF0KO0R
Ketoconazole
R9400W927I
4-Aminobenzoic Acid
TL2TJE8QTX
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM